Moreover, since retinopathy and nephropathy share pathophysiological mechanisms [86] and there is a defined correlation between severity of DR and diabetic nephropathy [87,88], renoprotective properties of SGLT-2 inhibitors [58] and GLP-1 RAs [89,90] should be translatable to retinopathy. The gene discussed is GLP1R; the disease is retinal disorder.